Women ‘Celebrating’ Their Abortions? Librarians’ Mental Health; $500M Drugmaker Fine

Note that some links may require registration or subscription.

In an interview with podcaster Joe Rogan, Sen. JD Vance (R-Ohio) said that women are “celebrating” their abortions and suggested liberals are more likely to be in “poor health and overweight.” (New York Times)

Meanwhile, some states are charging women who have miscarriages or stillbirths. (Marshall Project)

Supply chain issues were less likely to result in meaningful drug shortages in Canada compared with the U.S., a study in JAMA found.

Your black spatula is likely leaking chemicals into your cooking oil. (The Atlantic)

Health insurance enrollment under the Affordable Care Act marketplace is now open. (AP via ABC News)

The U.S. sanctioned members of La Linea, a fentanyl-smuggling Mexican cartel, the Treasury Department announced.

What is triggering the increase in road rage? (Washington Post)

The current political and social climate has librarians struggling with mental health issues. (New York Times)

A 2022-2024 outbreak of serogroup Y meningococcal disease sickened 36 people in Virginia and led to seven deaths. (Morbidity and Mortality Weekly Report)

Xylazine or “tranq” addiction in pregnancy poses a “terrifying” threat to women and their babies. (NPR)

A student in Georgia with tuberculosis may have exposed hundreds. (USA Today)

Schools are banning Crocs, citing “safety” reasons. (People)

The New York Times dives into the role mucus plays in health.

Companies participating in FDA’s opioid analgesic disposal program will now need to provide prepaid mail-back envelopes to pharmacies that request them.

Utah announced that avian flu has been confirmed in eight of the state’s commercial dairy farms. (Salt Lake Tribune)

Conservative groups in Montana are working to stop Medicaid expansion in the state. (KFFHealth News)

NIH launched an HIV prevention trial to examine the safety and acceptability of a novel rectal HIV microbicide douche containing the antiretroviral tenofovir.

The European Commission fined drugmaker Teva more than $500 million for improperly seeking to protect the patent on glatiramer acetate (Copaxone), a multiple sclerosis drug. (AP)

FDA formally rebuked Novo Nordisk over production issues at one of its semaglutide (Ozempic, Wegovy) and insulin manufacturing plants. (Fierce Pharma)